Author Question: Given what you know about gender differences in educational attainment, which of the following ... (Read 64 times)

debasdf

  • Hero Member
  • *****
  • Posts: 570
Given what you know about gender differences in educational attainment, which of the following scenarios is most likely?
 
  a. Jane is more likely than Bob to earn her bachelor's degree.
  b. Bob is more likely than Jane to earn his PhD.
  c. Jane is more likely than Bob to earn her PhD.
  d. Bob is more likely to attend a two-year college than Jane.

Question 2

Why were guerrilla warfare and acts of terrorism rare in history?
 
  a. States typically observed rules of engagement on a battlefield.
  b. The modern media did not exist yet.
  c. People had a morality that prevented them from committing terrorist acts.
  d. The ability to inflict mass-destruction is a modern invention.



poopface

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

a

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

In the United States, there is a birth every 8 seconds, according to the U.S. Census Bureau's Population Clock.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library